{"id":"W7065352997","doi":"","title":"Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial","year":2022,"lang":"en","type":"article","venue":"Utrecht University Repository (Utrecht University)","topic":"Magnetic confinement fusion research","field":"Physics and Astronomy","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Dabrafenib; Trametinib; Glioma; Progressive disease; Radiation therapy; Phases of clinical research; Complete response; Response Evaluation Criteria in Solid Tumors; Chemotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002554853,0.001480422,0.002053716,0.0005147184,0.0003267397,0.001208815,0.0009891646,0.001077314,0.002688099],"category_scores_gemma":[0.0009342368,0.0005776641,0.00156944,0.0006786793,0.0006280689,0.001202787,0.0005347619,0.002268607,0.0006040055],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001058649,"about_ca_system_score_gemma":0.001749801,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001124845,"about_ca_topic_score_gemma":0.003015527,"domain_scores_codex":[0.9994382,0.0002584934,0.00004930479,0.0000981894,0.00004527496,0.0001104682],"domain_scores_gemma":[0.999206,0.00007699088,0.0002574675,0.00005636266,0.00004807198,0.0003549912],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9122106,0.01638627,0.008645543,0.0007970574,0.001711673,0.0001796745,0.0001441634,0.001013207,0.007874724,0.0002001596,0.002371047,0.04846608],"study_design_scores_gemma":[0.8696861,0.1182915,0.008462785,0.00002703613,0.0006599934,0.00023156,0.00003481686,0.0006376867,0.0006727969,0.0001326662,0.001140857,0.00002225208],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943453,0.002167484,0.0001964038,0.0003777365,0.00008619894,0.001316867,0.0007430073,0.0000544746,0.0007125969],"genre_scores_gemma":[0.9921783,0.001991739,0.001094293,0.0006600755,0.0001746071,0.001304594,0.001814772,0.00001652612,0.0007650831],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002688099,"threshold_uncertainty_score":0.01351148,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01659609138765078,"score_gpt":0.2232773724142677,"score_spread":0.2066812810266169,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}